Trial Profile
Combining Glucagon and Insulin Infusion with Glucose Sensing in Subcutaneous Adipose Tissue of Type 1 Diabetes Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2018
Price :
$35
*
At a glance
- Drugs Glucagon (Primary) ; Insulin aspart; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 14 Feb 2018 Status changed from recruiting to completed.
- 29 Jul 2015 New trial record